Search Results - "Sternieri, Emilio"
-
1
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients
Published in European journal of clinical pharmacology (01-05-2008)“…Background The marketing of sumatriptan, a selective serotonin (5-HT) 1B/1D agonist, first of the class of triptans, has increased the therapeutic options for…”
Get full text
Journal Article -
2
Medication overuse and chronic migraine: a critical review according to clinical pharmacology
Published in Expert opinion on drug metabolism & toxicology (01-07-2015)“…Chronic migraine is often complicated by medication-overuse headache (MOH), a headache due to excessive intake of acute medications. Chronic migraine and MOH…”
Get more information
Journal Article -
3
Methadone—metabolism, pharmacokinetics and interactions
Published in Pharmacological research (01-12-2004)“…The pharmacokinetics of methadone varies greatly from person to person; so, after the administration of the same dose, considerably different concentrations…”
Get full text
Journal Article -
4
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment
Published in Journal of headache and pain (01-02-2011)“…Triptans, selective 5-HT1B/1D receptor agonists, are specific drugs for the acute treatment of migraine that have the same mechanism of action. Here, it is…”
Get full text
Journal Article -
5
Past, Present, and Future Prospects of Medication-Overuse Headache Classification
Published in Headache (01-07-2008)“…The 1988 classification by the International Headache Society (IHS) first defined drug‐induced headache as a specific disorder, belonging to secondary…”
Get full text
Journal Article -
6
Pharmacoepidemiology of triptans in a headache centre
Published in Cephalalgia (01-07-2010)“…The aims of this survey were: (i) to examine the pharmacoepidemiology of triptans in a headache centre; (ii) to compare the characteristics of patients who…”
Get more information
Journal Article -
7
Clinical pharmacology of topiramate in migraine prevention
Published in Expert opinion on drug metabolism & toxicology (01-09-2011)“…Migraine is a widespread disorder. Migraine patients experience worse health-related quality of life than the general population. The availability of effective…”
Get more information
Journal Article -
8
Similarities and Differences Between Chronic Migraine and Episodic Migraine
Published in Headache (01-01-2007)“…Objective.—To quantify and characterize the similarities and the differences between chronic migraine (CM) patients with medication overuse and episodic…”
Get full text
Journal Article -
9
Production of lipid hydroperoxides and depletion of reduced glutathione in liver mitochondria after acute ethanol administration to rats
Published in Toxicology letters (01-12-1992)“…It has been found that acute ethanol (EtOH) intoxication to rats caused approximately 40% depletion of mitochondrial reduced glutathione (GSH). A GSH reduction…”
Get more information
Journal Article -
10
Past, Present, and Future Prospects of Medication-Overuse Headache Classification
Published in Headache (14-09-2007)Get full text
Journal Article -
11
Focus on headache as an adverse reaction to drugs
Published in Journal of headache and pain (01-08-2009)“…There are a large number of drugs inducing headache as an adverse reaction. Nevertheless, headaches as adverse reactions to drugs have received limited…”
Get full text
Journal Article -
12
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments
Published in Expert opinion on drug metabolism & toxicology (01-12-2006)“…Recent progress in the treatment of primary headaches has made available specific, effective and safe medications for these disorders, which are widely spread…”
Get more information
Journal Article -
13
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments
Published in Expert opinion on drug metabolism & toxicology (01-12-2006)“…The present part II review highlights pharmacokinetic drug-drug interactions (excluding those of minor severity) of medications used in prophylactic treatment…”
Get more information
Journal Article -
14
Serum time course of naltrexone and 6 β-naltrexol levels during long term treatment in drug addicts
Published in Drug and alcohol dependence (01-11-1998)“…The pharmacokinetics of naltrexone have been scarcely explored in patients during chronic treatment despite the observation that the pharmacological effect of…”
Get full text
Journal Article -
15
Effect of sumatriptan in different models of pain in rats
Published in European journal of pharmacology (23-08-2004)“…The effect of sumatriptan in two standard algesimetric tests and in a model of cephalalgia was evaluated in rats. The pain threshold was measured by the…”
Get full text
Journal Article -
16
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients
Published in Pharmacological research (01-08-2006)“…The combination of indomethacin, prochlorperazine and caffeine (IPC) is one of the most utilized formulations for the treatment of migraine attacks in Italy…”
Get full text
Journal Article -
17
Adverse reactions related to drugs for headache treatment: clinical impact
Published in European journal of clinical pharmacology (01-02-2005)“…To assess the clinical impact of adverse reactions related to drugs for primary headache treatment. We examined the adverse reactions to 360 medications…”
Get full text
Journal Article -
18
Headaches associated with chronic use of analgesics: a therapeutic approach
Published in Headache (01-08-1996)“…We evaluated 102 patients attending the Headache Study Center of the University of Modena who were suffering from chronic daily headache with daily drug…”
Get more information
Journal Article -
19
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients
Published in Journal of headache and pain (01-09-2005)“…Sumatriptan is a selective agonist of 5HT1 (1B/1D) receptors, which has proved to be effective and safe for the acute treatment of migraine attacks…”
Get full text
Journal Article -
20
Clinical considerations preliminary to application of the Italian Society for the Study of Headache's guidelines regarding migraine prophylactic treatment
Published in Journal of headache and pain (01-04-2003)“…The main goals of prophylactic treatment for migraine are to decrease headache attack frequency, length and intensity, to improve the efficacy of symptomatic…”
Get full text
Journal Article